Risk Flags
elevated_costHigh antipsychotic prescribing (65+)
Risk indicators are statistical patterns, not allegations. Learn more
2,266
Total Claims
$6.9M
Drug Cost
339
Beneficiaries
$20K
Cost/Patient
Risk Score Breakdown 14/100
Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+10
Cost per patient outlier+3
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
-39%
Opioid rate vs peers
3.8% vs 6.3% avg
+50%
Cost per patient vs peers
$20K vs $14K avg
Opioid Prescribing
3.8%
Opioid Rate
87
Opioid Claims
$1,816
Opioid Cost
21.8%
Long-Acting Rate
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 1,691 claims · $360K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apalutamide | 82 | $1.3M |
| Acalabrutinib Maleate | 73 | $1.1M |
| Lenalidomide | 33 | $723K |
| Ibrutinib | 34 | $515K |
| Cabozantinib S-Malate | 14 | $375K |
| Dasatinib | 27 | $347K |
| Ruxolitinib Phosphate | 21 | $330K |
| Pomalidomide | 12 | $275K |
| Niraparib Tosylate | 13 | $252K |
| Lenalidomide | 13 | $206K |
| Fedratinib Dihydrochloride | 12 | $158K |
| Sunitinib Malate | 14 | $88K |
| Apixaban | 85 | $54K |
| Rivaroxaban | 22 | $14K |
| Imatinib Mesylate | 19 | $4,004 |
Prescribing Profile
Patient Profile
73
Avg Age
59%
Female
2.18
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About